RE: 88E winter season and what now?6 Apr 2022 16:52
(Part 5)
So, how to apply an objective investor’s capital in a logical fashion? Looking at 88E, the market is valuing Project Icewine as follows: 88E mkt cap minus cash on the balance sheet minus the value of the Texas asset, so US$167m mkt cap minus cash on balance sheet right now (is US$24m fair? Anyone? Do we know if there were any cash outgoings over and above shares issued to service providers in lieu of cash payments over the winter season?) minus Texas value (call it $12m after the rise in oil price over the ownership period v’s $10m paid?). Thus, the market is valuing Icewine at US$131m approx. Remember, no value is being ascribed to either Yukon or Umiat/Peregrine.
The NN’s mkt cap today is $1.3bn. The CB is in the money so I’m not adding the debt portion to the EV calculation, ok?
So very, very roughly, the market is valuing Icewine + Talitha + Alkaid + Theta West at US$1.43bn, ascribing 91% of the value of the asset to the NN and 9% to 88E. Eagle-eyed readers will perhaps recall that for the purposes of comparative valuation, I was happy to work with a 90:10 ratio by value. So, on first glance the market looks to have got it just about right. Yes?
Actually, no. Firstly I reckon the ratio by value will end up being closer to 95:5 or 97:3 but it would be churlish to demand we all work with an amended ratio right now. But please keep it in the memory banks for the future. Secondly, in order to assess the respective upside risk an equity analyst must make a more subjective judgement about a company’s ability to deliver and execute the work required, and finance it, in order to achieve the objective of providing sufficient empirical evidence that debt providers (banks) or the sector (O&G companies) put up the cash to fund the development of the asset(s).
Here, there is a clear leader. PANR/GB spent $80m on 3D seismic and a further $150-200m on drilling and testing operations on the shared asset. As a result, its data collection and interpretation is, quite literally, two maybe three winter seasons ahead of 88E. In addition, is there anyone on this forum who would seriously argue the cost of capital/access to capital is going to be lower/easier in the next period for 88E v’s that of its NN?
Personal opinion? Once again, it leaves me assessing 88E’s mkt cap is too high today or that of the NN is too low. Probably a combination of the two.
What would the objective investor do if he had £100 to invest? Does he or she know better than the market? Surely the objective investor invests £90 in one equity and £10 in the other? I just don’t see any leverage in backing the minnow? Why buy a seat in the gods when a front row seat in the stalls is the same price? I’ll leave it to each individual reader to pick which one is which. /ends
PS I'm not charlotte. I'm scot126 here and the other place. End of.